Skip to main navigation

Search for:

Investors & Media
Contact Us

Our Focus
- Rare and Serious Liver Diseases
Our Research
Our Medicine
About Us
- Leadership
- Board
Careers

Home > Investors & Media

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print

Investor Relations

Change

Volume

52 Week High

52 Week Low

Sep 26, 2023 8:02 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

Sep 26, 2023

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases

Sep 05, 2023

Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences

Aug 02, 2023

Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates

Jul 26, 2023

Intercept to Announce Second Quarter 2023 Financial Results on August 2, 2023

View All Press Releases

Recent Events and Presentations

Sep 13, 2023 from 3:10 PM to 3:40 PM EDT

Baird Global Healthcare Conference

Sep 11, 2023 from 11:00 AM to 11:30 AM EDT

H.C. Wainwright 25th Annual Global Investment Conference

Aug 2, 2023 8:30 AM EDT

Q2 2023 Intercept Pharmaceuticals Earnings Call

Jun 23, 2023 8:30 AM EDT

Intercept Pharmaceuticals Conference Call

View All Events & Presentations

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print

Privacy Policy
Privacy Shield Policy
Corporate Compliance
Terms of Use
Contact Us
Cookie Preferences
Transparency Disclosures

305 Madison Avenue |Morristown, NJ 07960|T: (844) 782–4278

© 2023 Intercept Pharmaceuticals, Inc. US-NP-N/A-0161

Share

Facebook
LinkedIn
Twitter